Are you Dr. Walters?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5 Research Pkwy
Wallingford, CT 06492Phone+1 203-677-5752Fax+1 203-677-6691
Summary
- Dr. Ian Walters, MD is a hematologist in Wallingford, Connecticut. He is currently licensed to practice medicine in New York.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Surgery, 1993 - 1994
Albert Einstein College of MedicineClass of 1993
Certifications & Licensure
NY State Medical License 1994 - 2025
Clinical Trials
- A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Start of enrollment: 2017 Feb 09
Publications & Presentations
PubMed
- 157 citationsObjective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC.Riccardo Lencioni, Robert Montal, Ferran Torres, Joong-Won Park, Thomas Decaens
Journal of Hepatology. 2017-06-01 - 247 citationsBrivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean-Frédéric Blanc
Hepatology. 2014-11-01 - 20 citationsUsing Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular CarcinomaJean-Luc Raoul, Joong-Won Park, Yoon-Koo Kang, Richard S. Finn, Jun Suk Kim
Liver Cancer. 2014-04-16
Press Mentions
- Portage Biotech Highlights Initiation of the Invincible Trial, a Phase 2 Early Stage Breast Cancer Study from Intensity TherapeuticsMarch 25th, 2021
- Clinical Trial Tests in-Tumor Breast Cancer TherapyMarch 24th, 2021
- Juvenescence Scoops-up New Longevity IPMarch 9th, 2021
- Join now to see all
